This is a Validated Antibody Database (VAD) review about human cyclin E, based on 138 published articles (read how Labome selects the articles), using cyclin E antibody in all methods. It is aimed to help Labome visitors find the most suited cyclin E antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
cyclin E synonym: CCNE; pCCNE1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1a
  • western blot knockout validation; mouse; loading ...; fig s2b
Santa Cruz Biotechnology cyclin E antibody (SantaCruz, SC-247) was used in western blot on human samples (fig 1a) and in western blot knockout validation on mouse samples (fig s2b). Nature (2018) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D7T3U)
  • western blot knockout validation; mouse; loading ...; fig 3b
  • western blot; human; loading ...; fig 5b
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot knockout validation on mouse samples (fig 3b) and in western blot on human samples (fig 5b). Mol Pharmacol (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (E-4)
  • western blot; mouse; 1:500; loading ...; fig 2c
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-377100) was used in western blot on mouse samples at 1:500 (fig 2c). Nat Commun (2022) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:200; loading ...; fig 1d
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples at 1:200 (fig 1d). Int J Mol Sci (2022) ncbi
mouse monoclonal (HE12)
  • immunocytochemistry; human; loading ...; fig 2b
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in immunocytochemistry on human samples (fig 2b). iScience (2022) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig 3c
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples at 1:1000 (fig 3c). EMBO J (2022) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc247) was used in western blot on human samples (fig 3c). Sci Rep (2021) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig s1
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in western blot on human samples (fig s1). BMC Cancer (2021) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; loading ...; fig 4d
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on mouse samples (fig 4d). Biol Open (2021) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 6g
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 6g). elife (2020) ncbi
mouse monoclonal (E-4)
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology cyclin E antibody (Santa, sc-377100) was used in western blot on human samples at 1:500 (fig 4a). Biosci Rep (2019) ncbi
mouse monoclonal (E-4)
  • western blot; mouse; loading ...; fig 5l
Santa Cruz Biotechnology cyclin E antibody (Santa, sc-377100) was used in western blot on mouse samples (fig 5l). Aging Cell (2019) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1e
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 1e). Cell Rep (2019) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology cyclin E antibody (Santa, HE12) was used in western blot on human samples (fig 3a). Oncogene (2019) ncbi
mouse monoclonal (HE12)
  • other; human; loading ...; fig 4c
Santa Cruz Biotechnology cyclin E antibody (SantaCruz, sc-247) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (HE111)
  • immunoprecipitation; human; loading ...; fig 4a
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-248AC) was used in immunoprecipitation on human samples (fig 4a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1a
  • western blot knockout validation; mouse; loading ...; fig s2b
Santa Cruz Biotechnology cyclin E antibody (SantaCruz, SC-247) was used in western blot on human samples (fig 1a) and in western blot knockout validation on mouse samples (fig s2b). Nature (2018) ncbi
mouse monoclonal (HE12)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, SC-247) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 7c
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, HE12) was used in western blot on human samples (fig 7c). J Biol Chem (2017) ncbi
mouse monoclonal (HE12)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Santa Cruz Biotechnology cyclin E antibody (SantaCruz, SC-247) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 3d
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 3d). Sci Signal (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (B-7)
  • western blot; mouse; loading ...; fig 6a
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-48420) was used in western blot on mouse samples (fig 6a). Nat Commun (2016) ncbi
mouse monoclonal (E-4)
  • western blot; human; 1:1000; loading ...; fig 5a
In order to determine the effect of 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one on the induction of apoptosis and cell cycle arrest in human bladder carcinoma cells, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-377100) was used in western blot on human samples at 1:1000 (fig 5a). Mol Med Rep (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 3b
In order to discover that SDE2 is a genome surveillance factor regulated by proliferating cell nuclear antigen, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, HE12) was used in western blot on human samples (fig 3b). PLoS Genet (2016) ncbi
mouse monoclonal (HE12)
  • immunocytochemistry; human; 1:50; fig 2
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in immunocytochemistry on human samples at 1:50 (fig 2). Lipids Health Dis (2016) ncbi
mouse monoclonal (E-4)
  • western blot; human; fig 3
In order to test if interactions between pUL97 and other viral proteins can be detected by mass spectrometry-based approaches, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, E-4) was used in western blot on human samples (fig 3). Viruses (2016) ncbi
mouse monoclonal
  • western blot; human; fig 3
In order to test if interactions between pUL97 and other viral proteins can be detected by mass spectrometry-based approaches, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, E-4) was used in western blot on human samples (fig 3). Viruses (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 6a
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, HE12) was used in western blot on human samples (fig 6a). PLoS ONE (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 1
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 1). elife (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:200; loading ...; fig 2a
In order to describe how a CHK1 inhibitor reduces the growth of radioresistant breast cancer cells, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc247) was used in western blot on human samples at 1:200 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 1
In order to investigate proteolytic processing of p27, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (HE12)
  • immunoprecipitation; human; fig 5
  • western blot; human; fig 5
In order to report that inappropriate activation of CDK2 in S phase affects checkpoint kinase 1 inhibitor sensitivity in a subset of cell lines, Santa Cruz Biotechnology cyclin E antibody (santa Cruz, sc-247) was used in immunoprecipitation on human samples (fig 5) and in western blot on human samples (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (HE111)
  • western blot; human; 1:2000; loading ...; fig 4f
Santa Cruz Biotechnology cyclin E antibody (Santa, sc-248) was used in western blot on human samples at 1:2000 (fig 4f). J Pathol (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:2000; fig 7a,d
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in western blot on human samples at 1:2000 (fig 7a,d). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:500; loading ...; fig 7d
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples at 1:500 (fig 7d). Angiogenesis (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 6e
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in western blot on human samples (fig 6e). BMC Cancer (2015) ncbi
mouse monoclonal (HE12)
  • immunocytochemistry; human; 1:150; loading ...; fig 4b
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in immunocytochemistry on human samples at 1:150 (fig 4b). Cell Cycle (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 1
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 1). J Biomed Sci (2015) ncbi
mouse monoclonal (E-4)
  • western blot; mouse; fig 9a
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-377100) was used in western blot on mouse samples (fig 9a). J Cell Biol (2015) ncbi
mouse monoclonal (E-4)
  • western blot; human; 1:1000; fig 1
In order to analyze the anti-cancer effect of fucoidan on human colon cancer cells, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-377100) was used in western blot on human samples at 1:1000 (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, HE12) was used in western blot on human samples (fig 5). Biol Open (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:500; fig 1
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, SC-247) was used in western blot on human samples at 1:500 (fig 1). Int J Oncol (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 1
In order to study the inhibition of cell proliferation by a novel pathway of Skp2 degradation due to statin-induced depletion of geranylgeranyl pyrophosphate, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, HE12) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; fig 1,2,3,4,5,6
In order to determine the role of progesterone receptor activation in increasing protein turnover and downregulation of GATA3 transcriptional repression which promotes breast tumor growth, Santa Cruz Biotechnology cyclin E antibody (santa cruz, sc-247) was used in western blot on mouse samples (fig 1,2,3,4,5,6). Breast Cancer Res (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:200; loading ...; fig 2d
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples at 1:200 (fig 2d). Mol Oncol (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to study p27 and c-Myc in chronic lymphocytic leukemia, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 4d
Santa Cruz Biotechnology cyclin E antibody (Santa, Sc-247) was used in western blot on human samples (fig 4d). Oncotarget (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Technology, sc-247) was used in western blot on human samples . Mol Cancer (2014) ncbi
mouse monoclonal (HE12)
  • western blot; mouse
Santa Cruz Biotechnology cyclin E antibody (SCBT, sc-247) was used in western blot on mouse samples . Leukemia (2014) ncbi
mouse monoclonal (HE12)
  • flow cytometry; human
In order to study NK function in solid tumors, Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, HE12) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (HE12)
  • western blot; mouse
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, sc-247) was used in western blot on mouse samples . Mol Pharmacol (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples . Cancer Lett (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz Biotechnology, HE-12) was used in western blot on human samples . Nucleic Acids Res (2013) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 3
Santa Cruz Biotechnology cyclin E antibody (Santa Cruz, sc-247) was used in western blot on human samples (fig 3). Clin Cancer Res (2010) ncbi
Abcam
mouse monoclonal (CCNE1/2460)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a, 1b
Abcam cyclin E antibody (Abcam, CCNE1/2460) was used in immunohistochemistry - paraffin section on human samples (fig 1a, 1b). Curr Oncol (2022) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; human; 1:250; loading ...; fig 3e
Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on human samples at 1:250 (fig 3e). Cancer Res Treat (2021) ncbi
domestic rabbit monoclonal (EP435E)
  • immunohistochemistry - paraffin section; rat; 1:300; loading ...; fig 9b
Abcam cyclin E antibody (Abcam, Ab33911) was used in immunohistochemistry - paraffin section on rat samples at 1:300 (fig 9b). Mol Ther Nucleic Acids (2020) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:500; loading ...; fig 5a
Abcam cyclin E antibody (Abcam, ab3927) was used in western blot on human samples at 1:500 (fig 5a). Int J Mol Med (2020) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on human samples at 1:1000 (fig 4b). Biol Res (2019) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; human; loading ...; fig 3d
Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on human samples (fig 3d). Biosci Rep (2019) ncbi
mouse monoclonal (HE12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a, 1b
  • western blot; human; 1:1000; loading ...; fig 3a, 3c
Abcam cyclin E antibody (Abcam, ab3927) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a, 1b) and in western blot on human samples at 1:1000 (fig 3a, 3c). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; rat; loading ...; fig 2d
Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on rat samples (fig 2d). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EPR194)
  • western blot; human; 1:1000; loading ...; fig 6b
Abcam cyclin E antibody (Abcam, ab133266) was used in western blot on human samples at 1:1000 (fig 6b). Cancer Sci (2019) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; pigs ; 1:2000; fig 1d
Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on pigs samples at 1:2000 (fig 1d). Cell Physiol Biochem (2018) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; human; loading ...; fig s1c
In order to identify a positive feedback loop where the cell cycle regulatory factor Spy1 activates ERK1/2 in a MEK-independent fashion, Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on human samples (fig s1c). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:5000; loading ...; fig s2c
Abcam cyclin E antibody (Abcam, ab71535) was used in western blot on mouse samples at 1:5000 (fig s2c). Science (2016) ncbi
domestic rabbit monoclonal (EP435E)
  • western blot; human; 1:2000; loading ...; fig 4a
Abcam cyclin E antibody (Abcam, ab33911) was used in western blot on human samples at 1:2000 (fig 4a). Oncotarget (2016) ncbi
mouse monoclonal (HE12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5a
  • western blot; human; 1:1000; loading ...; fig 3c
Abcam cyclin E antibody (Abcam, Ab3927) was used in immunohistochemistry - paraffin section on human samples (fig 5a) and in western blot on human samples at 1:1000 (fig 3c). Oncotarget (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; fig 3
Abcam cyclin E antibody (Abcam, ab3927) was used in western blot on human samples at 1:1000 (fig 3). J Hematol Oncol (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 2
Abcam cyclin E antibody (Abcam, ab3927) was used in western blot on human samples (fig 2). Genetics (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human
  • western blot; chicken
Abcam cyclin E antibody (Abcam, H-12) was used in western blot on human samples and in western blot on chicken samples . PLoS Pathog (2014) ncbi
domestic rabbit monoclonal (SP146)
  • immunohistochemistry - paraffin section; human
Abcam cyclin E antibody (Abcam, ab135380) was used in immunohistochemistry - paraffin section on human samples . Cancer Lett (2014) ncbi
Invitrogen
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 4b
In order to investigate ZBTB33 modulation of the cyclin D1/cyclin E1/RB1/E2F pathway, Invitrogen cyclin E antibody (ThermoFisher Scientific, MA5-14336) was used in western blot on human samples (fig 4b). J Biol Chem (2016) ncbi
mouse monoclonal (HE172)
  • western blot; human; fig 4
In order to investigate proteolytic processing of p27, Invitrogen cyclin E antibody (Invitrogen, 32-1500) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (HE12)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2
In order to correlate expression of proteins in ErbB family signaling pathways with the clinical efficacy of lapatinib, Invitrogen cyclin E antibody (Thermo Scientific, HE12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (HE12)
  • flow cytometry; human; fig 3
In order to study the function of the PIF1 gene in apoptosis, Invitrogen cyclin E antibody (Invitrogen, 32-1600) was used in flow cytometry on human samples (fig 3). Cancer Res (2011) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 9
In order to identify nuclear envelope proteins that affect cell cycle progression, Invitrogen cyclin E antibody (Invitrogen, 32-1600) was used in western blot on human samples (fig 9). PLoS ONE (2011) ncbi
mouse monoclonal (HE12)
  • western blot; human; 0.5 ug/ml; fig s2
In order to report that infection with N. gonorrhoeae causes altered amphiregulin processing and release in human epithelial cells, Invitrogen cyclin E antibody (Zymed, HE-12) was used in western blot on human samples at 0.5 ug/ml (fig s2). PLoS ONE (2011) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:200; fig 6e
In order to test if small molecules can restore p27 expression in cancer cells, Invitrogen cyclin E antibody (Thermo Scientific, HE12) was used in western blot on human samples at 1:200 (fig 6e). BMC Biol (2010) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1 ug/ml; fig 2
In order to investigate the cellular effects of chlorophyllin treatment, Invitrogen cyclin E antibody (Biosource, HE12) was used in western blot on human samples at 1 ug/ml (fig 2). Int J Cancer (2009) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to elucidate how treatment with gallotannin prevents cancer, Invitrogen cyclin E antibody (Biosource, HE 12) was used in western blot on human samples . Mol Carcinog (2007) ncbi
mouse monoclonal (HE12)
  • western blot; human; 2.6 ug/ml; fig 4
In order to elucidate how Neisseria gonorrhoeae affects the cell cycle of human cells, Invitrogen cyclin E antibody (Zymed, HE12) was used in western blot on human samples at 2.6 ug/ml (fig 4). FASEB J (2007) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:200
In order to assess the role of the SKP2 F-box protein in p27 regulation in prostate cancer, Invitrogen cyclin E antibody (Neomarkers, MS-870) was used in western blot on human samples at 1:200. BMC Cell Biol (2002) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D7T3U)
  • western blot; human; 1:2000; loading ...; fig 3e
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot on human samples at 1:2000 (fig 3e). iScience (2022) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 5b). Pharmaceutics (2022) ncbi
domestic rabbit monoclonal (D7T3U)
  • other; mouse; loading ...; fig 6j, 7j
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in other on mouse samples (fig 6j, 7j). Autophagy (2022) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology cyclin E antibody (Cell Signal, 4129) was used in western blot on human samples (fig 3e). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; rat; loading ...; fig 5e
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 20808S) was used in western blot on rat samples (fig 5e). J Cell Biol (2021) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; human; 1:1000; loading ...; fig s3f
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 20808) was used in western blot on human samples at 1:1000 (fig s3f). Oncogene (2021) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129) was used in western blot on human samples (fig 5e). Oncogene (2021) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; mouse; loading ...; fig s2c
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot on mouse samples (fig s2c). Blood (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology cyclin E antibody (cell signaling technology, 4136) was used in western blot on human samples (fig 4c). Front Oncol (2020) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology cyclin E antibody (CST, 4129) was used in western blot on human samples (fig 5a). Breast Cancer Res (2021) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology cyclin E antibody (Cell Signaling, HE12) was used in western blot on mouse samples (fig 4b). PLoS ONE (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 5d
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4136) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5d). Oncol Rep (2020) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; mouse; loading ...; fig 4c
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808S) was used in western blot on mouse samples (fig 4c). Drug Metab Dispos (2020) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; human; loading ...; fig 10a
  • western blot; rat; loading ...; fig 7a
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot on human samples (fig 10a) and in western blot on rat samples (fig 7a). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot on human samples (fig 1a). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot on human samples (fig 1b). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 20808) was used in western blot on human samples (fig 5a). Cancer Res (2019) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; 1:1000; loading ...; fig s12f
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129) was used in western blot on mouse samples at 1:1000 (fig s12f). Science (2019) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig s1f
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129S) was used in western blot on human samples at 1:1000 (fig s1f). EMBO J (2018) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; loading ...; fig 2h
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on mouse samples (fig 2h). Cancer Res (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 5). Exp Neurol (2018) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129s) was used in western blot on human samples at 1:1000 (fig 3c). Am J Cancer Res (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4136) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig S1A
Cell Signaling Technology cyclin E antibody (Cell Signaling, HE12) was used in western blot on human samples (fig S1A). Mol Cell (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig s3b
Cell Signaling Technology cyclin E antibody (Cell signaling, 4129) was used in western blot on human samples (fig s3b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot on human samples at 1:1000 (fig 3a). Oncol Lett (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1d
In order to research the role of polo like kinase 1 in MTOR complex 1 and autophagy, Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 1d). Autophagy (2017) ncbi
domestic rabbit monoclonal (D7T3U)
  • western blot knockout validation; mouse; loading ...; fig 3b
  • western blot; human; loading ...; fig 5b
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology cyclin E antibody (Cell Signaling, 20808) was used in western blot knockout validation on mouse samples (fig 3b) and in western blot on human samples (fig 5b). Mol Pharmacol (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Cell Signaling Technology cyclin E antibody (Cell Signaling Tech, 4129) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:1000 (fig s3b). Oncogene (2017) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; fig s1
Cell Signaling Technology cyclin E antibody (Cell Signal, 4129) was used in western blot on mouse samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples . Nucleic Acids Res (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 4
Cell Signaling Technology cyclin E antibody (Cell signaling, 4129S) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4136) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1b
In order to study quinacrine-induced apoptosis, Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 1b). Biochem Pharmacol (2016) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; 1:1000; loading ...; fig s2d
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, Cell Signaling Technology cyclin E antibody (Cell Signaling, HE12) was used in western blot on mouse samples at 1:1000 (fig s2d). Nat Commun (2016) ncbi
mouse monoclonal (HE12)
  • immunohistochemistry - paraffin section; human; fig 1a
Cell Signaling Technology cyclin E antibody (Cell Signaling, HE12) was used in immunohistochemistry - paraffin section on human samples (fig 1a). BMC Cancer (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; fig 3
In order to investigate factors that control PHD1 activity, Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:1000 (fig 3). J Cell Sci (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
In order to characterize modulation of microtubular structure and HSP90alpha chaperone activity against prostate cancer by 4-hydroxybenzoic acid derivatives as HDAC6-specific inhibitors, Cell Signaling Technology cyclin E antibody (Cell signaling, 4129) was used in western blot on human samples (fig 5). Biochem Pharmacol (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 3b
In order to study MARCKS signaling and how it expresses endothelial cell proliferation and vascular smooth muscle through a KIS-, p27kip1- dependent mechanism, Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129) was used in western blot on human samples (fig 3b). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 4c
In order to report that expression of HIF2alpha is regulated by the deubiquitylase Cezanne in an E2F1-dependent manner, Cell Signaling Technology cyclin E antibody (Cell Signaling, HE12) was used in western blot on human samples (fig 4c). J Cell Sci (2015) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; 1:1000; fig 2
Cell Signaling Technology cyclin E antibody (Cell Signaling Tech, 4129) was used in western blot on mouse samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:750; fig 2
In order to investigate the contribution of cyclobutane pyrimidine dimers to UVB-induced changes of gene expression, Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:750 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Cell Signaling Technology cyclin E antibody (Cell signaling, 4129) was used in western blot on human samples (fig 5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:500
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129S) was used in western blot on human samples at 1:500. Br J Pharmacol (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 1
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129) was used in western blot on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 5). Int J Mol Sci (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to study CREB in acute myeloid leukemia, Cell Signaling Technology cyclin E antibody (Cell Signaling, HE12) was used in western blot on human samples . Leukemia (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 6e
Cell Signaling Technology cyclin E antibody (Cell Signaling Technologies, 4129) was used in western blot on human samples (fig 6e). Mol Cell (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples . J Natl Cancer Inst (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to evaluate large subunit ribosomal proteins as therapeutic targets for melanoma, Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples . Pigment Cell Melanoma Res (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 6e). Mol Endocrinol (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to study the involvement of RASSF1A inactivation in carcinogenesis, Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology cyclin E antibody (Cell Signaling Technology, 4129) was used in western blot on human samples . Cell Signal (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:3000
Cell Signaling Technology cyclin E antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:3000. Exp Hematol (2012) ncbi
BD Biosciences
mouse monoclonal (HE12)
  • western blot; human
In order to show that that BLM undergoes K48-linked ubiquitylation and subsequent degradation during mitosis via Fbw7alpha, BD Biosciences cyclin E antibody (BD, 551159) was used in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human
BD Biosciences cyclin E antibody (BD Biosciences, 551159) was used in western blot on human samples . Biol Pharm Bull (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to study the promotion of c-Myc degradation by BLM helicase and its effect on tumor initiation, BD Biosciences cyclin E antibody (BD Pharmingen, 551159) was used in western blot on human samples . J Cell Sci (2013) ncbi
Articles Reviewed
  1. Bahn M, Yu D, Lee M, Jo S, Lee J, Kim H, et al. Central role of Prominin-1 in lipid rafts during liver regeneration. Nat Commun. 2022;13:6219 pubmed publisher
  2. Aboouf M, Armbruster J, Thiersch M, Guscetti F, Kristiansen G, Schraml P, et al. Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher
  3. Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, et al. RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 2022;25:105184 pubmed publisher
  4. Cai S, Hu T, Venkatesan M, Allam M, Schneider F, Ramalingam S, et al. Multiplexed protein profiling reveals spatial subcellular signaling networks. iScience. 2022;25:104980 pubmed publisher
  5. Paulmann C, Spallek R, Karpiuk O, Heider M, Sch xe4 ffer I, Zecha J, et al. The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. EMBO J. 2022;41:e110871 pubmed publisher
  6. Deshmukh D, Xu J, Yang X, Shimelis H, Fang S, Qiu Y. Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6. Pharmaceutics. 2022;14: pubmed publisher
  7. Tamura S, Hayashi T, Ichimura T, Yaegashi N, Abiko K, Konishi I. Characteristic of Uterine Rhabdomyosarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor. Curr Oncol. 2022;29:2350-2363 pubmed publisher
  8. Vessey K, Jobling A, Tran M, Wang A, Greferath U, Fletcher E. Treatments targeting autophagy ameliorate the age-related macular degeneration phenotype in mice lacking APOE (apolipoprotein E). Autophagy. 2022;18:2368-2384 pubmed publisher
  9. Chiang C, Hong Y. In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy. Sci Rep. 2021;11:18172 pubmed publisher
  10. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed publisher
  11. Moon S, Lee H, Kim S, Hong J, Chun S, Lee H, et al. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. BMC Cancer. 2021;21:931 pubmed publisher
  12. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed publisher
  13. Wu Y, Guo Q, Ju X, Hu Z, Xia L, Deng Y, et al. HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway. Oncogene. 2021;40:4770-4782 pubmed publisher
  14. Fischietti M, Eckerdt F, Blyth G, Arslan A, Mati W, Oku C, et al. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 2021;40:3273-3286 pubmed publisher
  15. Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021;137:1905-1919 pubmed publisher
  16. Su S, Li Q, Zhang M, Zhang P, Shen H, Zhang C. An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular Carcinoma. Front Oncol. 2020;10:593293 pubmed publisher
  17. Kaminska K, Akrap N, Staaf J, Alves C, Ehinger A, Ebbesson A, et al. Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer. Breast Cancer Res. 2021;23:26 pubmed publisher
  18. Qiao F, Law H, Krieger K, Clement E, Xiao Y, Buckley S, et al. Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs. Biol Open. 2021;10: pubmed publisher
  19. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  20. Zhang Y, Zhang L, Lu S, Xiang Y, Zeng C, He T, et al. Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis. Cancer Res Treat. 2021;53:184-198 pubmed publisher
  21. Brunner A, Suryo Rahmanto A, Johansson H, Franco M, Viiliäinen J, Gazi M, et al. PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. elife. 2020;9: pubmed publisher
  22. Wang W, Wang H, Xiang L, Ni T, Jin F, Deng J, et al. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer. Oncol Rep. 2020;44:77-90 pubmed publisher
  23. Jiao T, Yao X, Zhao Y, Zhou Y, Gao Y, Fan S, et al. Dexamethasone-Induced Liver Enlargement Is Related to PXR/YAP Activation and Lipid Accumulation but Not Hepatocyte Proliferation. Drug Metab Dispos. 2020;48:830-839 pubmed publisher
  24. Zhang Y, Mao X, Chen W, Guo X, Yu L, Jiang F, et al. A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation. Mol Ther Nucleic Acids. 2020;19:890-904 pubmed publisher
  25. Mlyczynska E, Kurowska P, Drwal E, Opydo Chanek M, Tworzydło W, Kotula Balak M, et al. Apelin and apelin receptor in human placenta: Expression, signalling pathway and regulation of trophoblast JEG‑3 and BeWo cells proliferation and cell cycle. Int J Mol Med. 2020;45:691-702 pubmed publisher
  26. Patel H, Tao N, Lee K, Huerta M, Arlt H, Mullarkey T, et al. Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors. Breast Cancer Res. 2019;21:146 pubmed publisher
  27. Liu G, Zhang Q, Xia L, Shi M, Cai J, Zhang H, et al. RNA-binding protein CELF6 is cell cycle regulated and controls cancer cell proliferation by stabilizing p21. Cell Death Dis. 2019;10:688 pubmed publisher
  28. Ji M, Wang Z, Chen J, Gu L, Chen M, Ding Y, et al. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin. Biosci Rep. 2019;39: pubmed publisher
  29. Wang X, Peng P, Pan Z, Fang Z, Lu W, Liu X. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52:34 pubmed publisher
  30. Fang D, Wang H, Li M, Wei W. α-bisabolol enhances radiotherapy-induced apoptosis in endometrial cancer cells by reducing the effect of XIAP on inhibiting caspase-3. Biosci Rep. 2019;39: pubmed publisher
  31. Zhang C, Zhu Q, Gu J, Chen S, Li Q, Ying L. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin. Biosci Rep. 2019;39: pubmed publisher
  32. Chen L, Yang R, Qiao W, Zhang W, Chen J, Mao L, et al. 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. Aging Cell. 2019;18:e12951 pubmed publisher
  33. Wang Z, Feng X, Molinolo A, Martin D, Vitale Cross L, Nohata N, et al. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res. 2019;: pubmed publisher
  34. Chakraborty A, Laukka T, Myllykoski M, Ringel A, Booker M, Tolstorukov M, et al. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science. 2019;363:1217-1222 pubmed publisher
  35. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  36. SCHADE A, Oser M, Nicholson H, DeCaprio J. Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB. Oncogene. 2019;38:4962-4976 pubmed publisher
  37. Fang G, Qi J, Huang L, Zhao X. LncRNA MRAK048635_P1 is critical for vascular smooth muscle cell function and phenotypic switching in essential hypertension. Biosci Rep. 2019;: pubmed publisher
  38. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  39. Allan L, Skowyra A, Rogers K, Zeller D, Clarke P. Atypical APC/C-dependent degradation of Mcl-1 provides an apoptotic timer during mitotic arrest. EMBO J. 2018;37: pubmed publisher
  40. Hou L, Xu J, Jiao Y, Li H, Pan Z, Duan J, et al. MiR-27b Promotes Muscle Development by Inhibiting MDFI Expression. Cell Physiol Biochem. 2018;46:2271-2283 pubmed publisher
  41. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  42. Geng Y, Michowski W, Chick J, Wang Y, Jecrois M, Sweeney K, et al. Kinase-independent function of E-type cyclins in liver cancer. Proc Natl Acad Sci U S A. 2018;115:1015-1020 pubmed publisher
  43. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  44. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  45. Oblinger J, Burns S, Huang J, Pan L, Ren Y, Shen R, et al. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol. 2018;299:299-307 pubmed publisher
  46. Ferraiuolo R, Tubman J, Sinha I, Hamm C, Porter L. The cyclin-like protein, SPY1, regulates the ER? and ERK1/2 pathways promoting tamoxifen resistance. Oncotarget. 2017;8:23337-23352 pubmed publisher
  47. Jiang J, Chen X, Liu H, Shao J, Xie R, Gu P, et al. Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM. Am J Cancer Res. 2017;7:245-259 pubmed
  48. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  49. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  50. Wyatt H, Laister R, Martin S, Arrowsmith C, West S. The SMX DNA Repair Tri-nuclease. Mol Cell. 2017;65:848-860.e11 pubmed publisher
  51. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  52. Fan Y, Mok C, Chan M, Zhang Y, Nal B, Kien F, et al. Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection. J Biol Chem. 2017;292:5070-5088 pubmed publisher
  53. Cai L, Wang H, Yang Q. CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma. Oncol Lett. 2017;13:51-56 pubmed publisher
  54. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  55. Ruf S, Heberle A, Langelaar Makkinje M, Gelino S, Wilkinson D, Gerbeth C, et al. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy. Autophagy. 2017;13:486-505 pubmed publisher
  56. Shimizu K, Fukushima H, Ogura K, Lien E, Nihira N, Zhang J, et al. The SCF?-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. Sci Signal. 2017;10: pubmed publisher
  57. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  58. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  59. Jablonska B, Gierdalski M, Chew L, Hawley T, Catron M, Lichauco A, et al. Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury. Nat Commun. 2016;7:13866 pubmed publisher
  60. Yu G, Dou Z, Jia Z. 5?bromo?3?(3?hydroxyprop?1?ynyl)?2H?pyran?2?one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways. Mol Med Rep. 2017;15:153-159 pubmed publisher
  61. Jo U, Cai W, Wang J, Kwon Y, D Andrea A, Kim H. PCNA-Dependent Cleavage and Degradation of SDE2 Regulates Response to Replication Stress. PLoS Genet. 2016;12:e1006465 pubmed publisher
  62. Kanakkanthara A, Jeganathan K, Limzerwala J, Baker D, Hamada M, Nam H, et al. Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation. Science. 2016;353:1549-1552 pubmed
  63. Zhang Y, Zhang Y, Zhong C, Xiao F. Cr(VI) induces premature senescence through ROS-mediated p53 pathway in L-02 hepatocytes. Sci Rep. 2016;6:34578 pubmed publisher
  64. Pozner A, Terooatea T, Buck Koehntop B. Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1. J Biol Chem. 2016;291:24538-24550 pubmed
  65. Cizkova K, Steigerova J, Gursky J, Ehrmann J. Stimulating effect of normal-dosing of fibrates on cell proliferation: word of warning. Lipids Health Dis. 2016;15:164 pubmed
  66. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  67. Steingruber M, Kraut A, Socher E, Sticht H, Reichel A, Stamminger T, et al. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins. Viruses. 2016;8: pubmed publisher
  68. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  69. Shen H, Zhao L, Feng X, Xu C, Li C, Niu Y. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer. Oncotarget. 2016;7:60407-60418 pubmed publisher
  70. Hossain M, Stillman B. Opposing roles for DNA replication initiator proteins ORC1 and CDC6 in control of Cyclin E gene transcription. elife. 2016;5: pubmed publisher
  71. Mansouri S, Singh S, Alamsahebpour A, Burrell K, Li M, Karabork M, et al. DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma. Oncotarget. 2016;7:56431-56446 pubmed publisher
  72. Zhang Y, Lai J, Du Z, Gao J, Yang S, Gorityala S, et al. Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress. Oncotarget. 2016;7:34688-702 pubmed publisher
  73. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  74. Mitxelena J, Apraiz A, Vallejo Rodríguez J, Malumbres M, Zubiaga A. E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation. Nucleic Acids Res. 2016;: pubmed
  75. Tang Y, Huang L, Lin W, Wang L, Tian Y, Shi D, et al. Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway. Oncotarget. 2016;7:18651-64 pubmed publisher
  76. Kan H, Huang Y, Li X, Liu D, Chen J, Shu M. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Oncotarget. 2016;7:14336-49 pubmed publisher
  77. Preet R, Siddharth S, Satapathy S, Das S, Nayak A, Das D, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016;105:23-33 pubmed publisher
  78. Podmirseg S, Jäkel H, Ranches G, Kullmann M, Sohm B, Villunger A, et al. Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene. 2016;35:4580-90 pubmed publisher
  79. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  80. Lee E, Jin D, Lee B, Kim Y, Han J, Shim Y, et al. Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro. BMC Cancer. 2015;15:982 pubmed publisher
  81. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed publisher
  82. Duchnowska R, Wysocki P, Korski K, Czartoryska Arłukowicz B, Niwińska A, Orlikowska M, et al. Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients. Oncotarget. 2016;7:550-64 pubmed publisher
  83. Sakurikar N, Thompson R, Montano R, Eastman A. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase. Oncotarget. 2016;7:1380-94 pubmed publisher
  84. Seidel C, Schnekenburger M, Mazumder A, Teiten M, Kirsch G, Dicato M, et al. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer. Biochem Pharmacol. 2016;99:31-52 pubmed publisher
  85. Yu D, Makkar G, Dong T, Strickland D, Sarkar R, Monahan T. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism. PLoS ONE. 2015;10:e0141397 pubmed publisher
  86. Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, et al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120 pubmed publisher
  87. Abu Alainin W, Gana T, Liloglou T, Olayanju A, Barrera L, Ferguson R, et al. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. J Pathol. 2016;238:423-33 pubmed publisher
  88. Leve F, Peres Moreira R, Binato R, Abdelhay E, Morgado Díaz J. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. PLoS ONE. 2015;10:e0139094 pubmed publisher
  89. Maleszewska M, Vanchin B, Harmsen M, Krenning G. The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence. Angiogenesis. 2016;19:9-24 pubmed publisher
  90. Bailey M, Singh T, Mero P, Moffat J, Hieter P. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Genetics. 2015;201:885-95 pubmed publisher
  91. Kumarasamy V, Shin Y, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599 pubmed publisher
  92. Restall I, Parolin D, Daneshmand M, Hanson J, Simard M, Fitzpatrick M, et al. PKCι depletion initiates mitotic slippage-induced senescence in glioblastoma. Cell Cycle. 2015;14:2938-48 pubmed publisher
  93. Moniz S, Bandarra D, Biddlestone J, Campbell K, Komander D, Bremm A, et al. Cezanne regulates E2F1-dependent HIF2α expression. J Cell Sci. 2015;128:3082-93 pubmed publisher
  94. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed publisher
  95. Cardona M, López J, Serafín A, Rongvaux A, Inserte J, García Dorado D, et al. Executioner Caspase-3 and 7 Deficiency Reduces Myocyte Number in the Developing Mouse Heart. PLoS ONE. 2015;10:e0131411 pubmed publisher
  96. Boros G, Miko E, Muramatsu H, Weissman D, Emri E, van der Horst G, et al. Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA. PLoS ONE. 2015;10:e0131141 pubmed publisher
  97. Ahn J, Kim S, Na W, Baek S, Kim J, Min K, et al. SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase. Nucleic Acids Res. 2015;43:6321-33 pubmed publisher
  98. Xie C, Wei D, Zhao L, Marchetto S, Mei L, Borg J, et al. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol. 2015;209:721-37 pubmed publisher
  99. Kharat S, Tripathi V, Damodaran A, Priyadarshini R, Chandra S, Tikoo S, et al. Mitotic phosphorylation of Bloom helicase at Thr182 is required for its proteasomal degradation and maintenance of chromosomal stability. Oncogene. 2016;35:1025-38 pubmed publisher
  100. Han Y, Lee J, Lee S. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep. 2015;12:3446-3452 pubmed publisher
  101. Morra F, Luise C, Merolla F, Poser I, Visconti R, Ilardi G, et al. FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. Oncotarget. 2015;6:12697-709 pubmed
  102. Kratz A, Bärenz F, Richter K, Hoffmann I. Plk4-dependent phosphorylation of STIL is required for centriole duplication. Biol Open. 2015;4:370-7 pubmed publisher
  103. Susanto J, Colvin E, Pinese M, Chang D, Pajic M, Mawson A, et al. The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo. Int J Oncol. 2015;46:2223-30 pubmed publisher
  104. Ishihara S, Yasuda M, Ishizu A, Ishikawa M, Shirato H, Haga H. Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget. 2015;6:4602-14 pubmed
  105. Barrichon M, Hadi T, Wendremaire M, Ptasinski C, Seigneuric R, Marcion G, et al. Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells. Br J Pharmacol. 2015;172:2974-90 pubmed publisher
  106. Su C, Zhang C, Tecle A, Fu X, He J, Song J, et al. Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation. J Biol Chem. 2015;290:7208-20 pubmed publisher
  107. Li Z, Xiao J, Hu K, Wang G, Li M, Zhang J, et al. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma. Int J Mol Sci. 2015;16:2294-306 pubmed publisher
  108. Vosper J, Masuccio A, Kullmann M, Ploner C, Geley S, Hengst L. Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation. Oncotarget. 2015;6:2889-902 pubmed
  109. Chae H, Mitton B, Lacayo N, Sakamoto K. Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA. Leukemia. 2015;29:1379-89 pubmed publisher
  110. Izzo F, Mercogliano F, Venturutti L, Tkach M, Inurrigarro G, Schillaci R, et al. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Res. 2014;16:491 pubmed publisher
  111. Gasser J, Inuzuka H, Lau A, Wei W, Beroukhim R, Toker A. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol Cell. 2014;56:595-607 pubmed publisher
  112. Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, König L, et al. PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. PLoS Pathog. 2014;10:e1004514 pubmed publisher
  113. Greve K, Lindgreen J, Terp M, Pedersen C, Schmidt S, Mollenhauer J, et al. Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability. Mol Oncol. 2015;9:437-49 pubmed publisher
  114. Caraballo J, Acosta J, Cortés M, Albajar M, Gomez Casares M, Batlle López A, et al. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle. Oncotarget. 2014;5:4694-708 pubmed
  115. Dai X, North B, Inuzuka H. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways. Oncotarget. 2014;5:3307-15 pubmed
  116. Aydin I, Melamed R, Adams S, Castillo Martin M, Demir A, Bryk D, et al. FBXW7 mutations in melanoma and a new therapeutic paradigm. J Natl Cancer Inst. 2014;106:dju107 pubmed publisher
  117. Kardos G, Dai M, Robertson G. Growth inhibitory effects of large subunit ribosomal proteins in melanoma. Pigment Cell Melanoma Res. 2014;27:801-12 pubmed publisher
  118. Wang Y, Wang Z, Qi Z, Yin S, Zhang N, Liu Y, et al. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy. Mol Cancer. 2014;13:94 pubmed publisher
  119. Wang Y, Zhou D, Chen S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1. Mol Endocrinol. 2014;28:935-48 pubmed publisher
  120. Ram R, Mendiratta S, Bodemann B, Torres M, Eskiocak U, White M. RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. Mol Cell Biol. 2014;34:2350-8 pubmed publisher
  121. Kumar V, Palermo R, Talora C, Campese A, Checquolo S, Bellavia D, et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28:2324-35 pubmed publisher
  122. Matsumoto T, Tabata K, Suzuki T. The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. Biol Pharm Bull. 2014;37:633-41 pubmed
  123. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  124. Jackson D, Li H, Mitchell K, Joshi A, Elferink C. Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression. Mol Pharmacol. 2014;85:533-41 pubmed publisher
  125. Lin Q, Aihara A, Chung W, Li Y, Huang Z, Chen X, et al. LRH1 as a driving factor in pancreatic cancer growth. Cancer Lett. 2014;345:85-90 pubmed publisher
  126. Sengupta S, Jana S, Bhattacharyya A. TGF-?-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Cell Signal. 2014;26:240-52 pubmed publisher
  127. Chandra S, Priyadarshini R, Madhavan V, Tikoo S, Hussain M, Mudgal R, et al. Enhancement of c-Myc degradation by BLM helicase leads to delayed tumor initiation. J Cell Sci. 2013;126:3782-95 pubmed publisher
  128. Jullien L, Mestre M, Roux P, Gire V. Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Res. 2013;41:900-11 pubmed publisher
  129. Valdez B, Nieto Y, Murray D, Li Y, Wang G, Champlin R, et al. Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines. Exp Hematol. 2012;40:800-10 pubmed publisher
  130. Gagou M, Ganesh A, Thompson R, Phear G, Sanders C, Meuth M. Suppression of apoptosis by PIF1 helicase in human tumor cells. Cancer Res. 2011;71:4998-5008 pubmed publisher
  131. Korfali N, Srsen V, Waterfall M, Batrakou D, Pekovic V, Hutchison C, et al. A flow cytometry-based screen of nuclear envelope transmembrane proteins identifies NET4/Tmem53 as involved in stress-dependent cell cycle withdrawal. PLoS ONE. 2011;6:e18762 pubmed publisher
  132. Lofmark S, de Klerk N, Aro H. Neisseria gonorrhoeae infection induces altered amphiregulin processing and release. PLoS ONE. 2011;6:e16369 pubmed publisher
  133. Rico Bautista E, Yang C, Lu L, Roth G, Wolf D. Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells. BMC Biol. 2010;8:153 pubmed publisher
  134. Yang G, Chang B, Yang F, Guo X, Cai K, Xiao X, et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010;16:3171-81 pubmed publisher
  135. Chimploy K, Díaz G, Li Q, Carter O, Dashwood W, Mathews C, et al. E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin. Int J Cancer. 2009;125:2086-94 pubmed publisher
  136. Al Ayyoubi S, Gali Muhtasib H. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status. Mol Carcinog. 2007;46:176-86 pubmed
  137. Jones A, Jonsson A, Aro H. Neisseria gonorrhoeae infection causes a G1 arrest in human epithelial cells. FASEB J. 2007;21:345-55 pubmed
  138. Lu L, Schulz H, Wolf D. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC Cell Biol. 2002;3:22 pubmed